Athira Pharma Reports First Quarter 2022 Financial Results and Provides Pipeline and Business Updates

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

United States ,Australia ,Athira Pharma ,Simon Daggett ,Arthur Rosenthal ,Julie Rathbun ,Michael Panzara ,Lana Gloukhova ,Mark Litton ,Donald Mackenzie ,Peripheral Nerve Society ,Instagram ,Linkedin ,Twitter ,Nasdaq ,Schering ,Athira Pharma Inc ,Allergan ,Avanir Pharmaceuticals ,National Institutes Of Health ,World Health Organization ,Drug Regulatory Affairs ,American Society For Experimental Neurotherapeutics ,Exchange Commission ,Development Rd Expenses ,Securities Exchange ,Chief Executive Officer ,Lewy Bodies ,Grant Pickering ,Recent Highlights ,Open Label Extension ,Event Related Potential ,American Society ,United States Adopted Names ,Senior Vice President ,Vice President ,Drug Regulatory ,Vice President Drug Safety ,Vice President Clinical ,National Institute ,National Institutes ,Label Extension Study ,Open Label Extension Study ,Safety Monitoring Board ,Healthy Volunteers ,Rat Diabetic Neuropathy Model ,Pharma Inc ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Media Contact ,Consolidated Statement ,Comprehensive Loss ,Ended December ,Covid 19 ,Health ,Globe Newswire ,